Medical Weight Loss for Norwich, Connecticut Residents

Norwich, Connecticut residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Norwich through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Norwich: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Connecticut patients choose. Doctor review just $119 (medication separate).

Why Norwich Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Norwich it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across Connecticut tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

Norwich patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.

Our clinic sits in Costa Mesa, California, but if you live in Norwich, Connecticut, you receive the exact same physician-supervised care from Dr. Anjmun Sharma over telehealth, with no drive and no waiting room. We care for patients throughout downtown Norwich and the greater New London County area of southeastern Connecticut. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Norwich.

Whether you live in central Norwich or out toward the edges of Connecticut, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. Getting started in Norwich is simple: a Connecticut licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. New Hope Weight Loss serves patients throughout Connecticut by secure telehealth from our Costa Mesa, California clinic, bringing physician-supervised GLP-1 programs to your door without an office visit.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Norwich telehealth visits.

How Telehealth Works for Norwich

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Norwich and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Norwich door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Norwich

Where is the New Hope Weight Loss location serving Norwich?

The location serving Norwich is our Costa Mesa, California clinic, which is our only physical site. We care for Norwich, Connecticut patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Norwich patients?

It is the standard for Norwich. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Norwich in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Norwich patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Norwich patients.

What areas of Norwich do you serve?

We serve patients from across Norwich by telehealth, including downtown Norwich and the greater New London County area of southeastern Connecticut.

Is my health information private as a Norwich patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Norwich patients get the same confidentiality as any telehealth patient.

Norwich Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Norwich, Connecticut by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.